The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2016

Circadian rhythmicity in emerging mood disorders: state or trait marker?
A Grierson
I Hickie
S Naismith
D Hermans
E Scott
The University of Notre Dame Australia, elizabeth.scott@nd.edu.au

See next page for additional authors

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This article was originally published as:
Grierson, A., Hickie, I., Naismith, S., Hermans, D., Scott, E., & Scott, J. (2016). Circadian rhythmicity in emerging mood disorders: state
or trait marker?. International Journal of Bipolar Disorders, 4 (3).
Original article available here:
https://dx.doi.org/10.1186/s40345-015-0043-z

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/821. For more
information, please contact researchonline@nd.edu.au.

Authors
A Grierson, I Hickie, S Naismith, D Hermans, E Scott, and J Scott

This article is available at ResearchOnline@ND: https://researchonline.nd.edu.au/med_article/821

This is an Open Access article distributed in accordance with the Creative Commons Attribution 4.0
International license (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original author and source are credited.
See: https://creativecommons.org/licenses/by/4.0/
This article originally published in the International Journal of Bipolar Disorders available
at: https://dx.doi.org/10.1186/s40345-015-0043-z
Grierson, A., Hickie, I., Naismith, S., Hermens, D., Scott, E., and Scott, J. (2016) Circadian rhythmicity
in emerging mood disorders: state or trait marker? International Journal of Bipolar Disorders, 4(3).
doi: 10.1186/s40345-015-0043-z

Grierson et al. Int J Bipolar Disord (2016) 4:3
DOI 10.1186/s40345-015-0043-z

Open Access

RESEARCH

Circadian rhythmicity in emerging mood
disorders: state or trait marker?
Ashlee B. Grierson1, Ian B. Hickie1, Sharon L. Naismith2, Daniel F. Hermens1, Elizabeth M. Scott3,4 and Jan Scott5*

Abstract
Background: Circadian rhythm disturbances overlap with the symptoms of mood episodes and may trigger or
prolong mood symptoms. There is limited research on the role of circadian disturbances in mood disorders in young
people and/or first episode cases of unipolar and bipolar disorders.
Methods: Actigraphy was undertaken for about 14 days in 63 post-pubertal individuals aged 13–25 years with a
recent onset of a mood disorder meeting recognised diagnostic criteria. We examined associations between three
easily interpretable markers of circadian rhythm activity (amplitude, acrophase and rhythmicity index) and demography and clinical characteristics. Then, circadian markers were compared between diagnostic groups, controlling for
potential confounders.
Results: Longer duration of illness was correlated with reduced circadian rhythmicity and lower levels of activity over
24 h. A delay in the timing of maximum activity was associated with the level of manic but not depressive symptoms.
The circadian rhythmicity index differentiated unipolar from bipolar cases, and in bipolar but not unipolar disorder,
the rhythmicity was less robust in those with more severe manic or depressive symptoms.
Conclusions: Less robust circadian rhythmicity, especially associated with increasing symptom severity, may represent a more specific or a trait marker of young people with mood disorders who are at higher risk of a bipolar course
of illness.
Keywords: Circadian rhythm, Bipolar, Unipolar, Adolescence, Young adult, Trait
Background
Circadian rhythm disturbances are of considerable interest to mood disorder researchers as many of the phenomena that accompany disruptions in the sleep–wake cycle
overlap with the symptoms of mood episodes or may
trigger or prolong mood symptoms (e.g. McClung 2013;
Robillard et al. 2013a). However, most investigations
of circadian rhythm disruptions in mood disorders are
focused on older adult samples with established unipolar
(UP) or bipolar disorders (BD). Often these individuals
have a history of multiple mood episodes, accompanied
by a high prevalence of mental and physical comorbidities, complex treatment regimens and/or elevated body
mass index (BMI) (Geoffroy et al. 2015). As such, it is
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difficult to disentangle which abnormalities represent
causes and which are consequences of mood episodes
(Bellivier et al. 2015). There is limited research on the
role of circadian disturbances in UP and BD in young
people, especially related to first episode onset or the first
treated episode (e.g. Ritter et al. 2011; Castro et al. 2015;
Ng et al. 2015).
One of the problems in making comparisons between
studies undertaken in young people with emerging mood
disorders is that the sampling strategies and the parameters measured vary considerably between studies. For
example, some studies focus on individuals at high risk
of developing psychotic or mood disorders (identified by
the presence of attenuated symptoms or temperamental
style), whilst others recruit mixed samples of symptomatic and asymptomatic offspring of parents with UP or
BD (e.g. Jones et al. 2006; Adan et al. 2010; Hidalgo et al.
2009; Castro et al. 2015; Park et al. 2015). Most of these
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studies use self-report assessments of sleep patterns or
self-ratings of circadian rhythm such as the Morning–
Eveningness Questionnaire (MEQ) (Horne and Ostberg
1976); the studies that do use objective measures such
as actigraphy often focus on more traditional measures
of sleep, such as sleep latency, waking after sleep onset
and total sleep time (e.g. Castro et al. 2015). Studies
measuring circadian parameters and using actigraphy
have often recruited young people with a wide range of
disorders (anxiety, UP, BD, psychosis), but failed to take
into account in the analyses the other variables known to
influence circadian rhythms, such as age, pubertal status
or BMI, etc., (Adan et al. 2010; Mansour et al. 2005; Caci
et al. 2009; Kim et al. 2010; Tranel et al. 2015).
Despite the methodological heterogeneity (noted
above), there is a growing research literature on actigraphic measures of circadian rhythms in youth. However, the clinical translation of some of these studies is
reduced because many clinicians are unfamiliar with
the relevance of some measures and/or are uncertain
how to interpret some of the circadian parameters (e.g.
alpha, beta, mesor) (Bellivier et al. 2015). As such, it can
be helpful to select circadian markers that have shown
differences between young people with mood disorders
(compared to healthy control or other cases with mental
disorders), and that can be easily understood by clinicians. The three obvious circadian parameters are amplitude, acrophase and circadian rhythmicity index. Several
studies report lower 24-hour activity rhythms (amplitude) or changes in dim light melatonin onset for UP and
BD (Teicher et al. 1993; Armitage et al. 2004; Robillard
et al. 2013b; 2015), and for individuals at risk of BD (Bullock and Murray 2014; Castro et al. 2015). The timing of
maximal activity within a 24-h period (acrophase) has
shown mixed results in UP and BD (Teicher et al. 1993;
Robillard et al. 2013a; 2015), but there is emerging evidence of lower robustness of circadian rhythmicity in
broad populations of young patients compared to healthy
controls (e.g. Carpenter et al. 2015). The latter could be
an interesting avenue for youth research as Gonzalez and
colleagues (2014) recently demonstrated that a lower circadian rhythmicity index was a useful marker of illness
severity in adults with BD and was correlated with total
manic symptom score and with some individual manic
symptoms. However, rhythmicity in comparable populations of UP and BD cases remains unexplored.
This study examines the role of selected markers of circadian rhythmicity in emerging mood disorders in young
people aged 13–25 years who presented for the first
time to clinical services. We focused on three key, easily
interpretable parameters of circadian regulation, namely
amplitude, acrophase and the circadian rhythmicity
index. The aims were (a) to examine the associations
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between circadian parameters and age, gender, BMI,
duration of illness and symptom severity in the total sample; (b) to compare these circadian parameters in BD and
UP (after controlling for potential confounders).

Methods
Participants

With the approval of the Human Research Ethics Committee of The University of Sydney, individuals attending
the local youth mental health services in and around Sydney, Australia (Youth Mental Health Clinic at the Brain
& Mind Research Institute, at The University of Sydney,
and headspace in Campbelltown) were invited to participate in a series of studies of mental and physical health,
including research on sleep and actigraphy.
Individuals included in this study were aged
13–25 years, had a recent onset of a mood disorder
meeting DSM-IV R criteria (APA. 2000), and were willing and able to give written informed consent to participate and to comply with study procedures. In those
aged <16 years, additional written consent was obtained
from their parents or legal guardians. The exclusion criteria were (i) clinically assessed IQ <70 or intellectual
impairment, and/or history of head injury, (ii) mood disorder secondary to a medical condition or psychotic disorder, (iii) primary substance or alcohol misuse disorder,
(iv) risk of suicide or self-harm, (v) regular use of medications that affect sleep, melatonin, circadian rhythms or
alertness, (vi) evidence of other sleep (e.g. sleep apnoea,
narcolepsy), neurological (e.g. epilepsy) or primary medical conditions that could explain the current depression
and/or contribute to sleep–wake dysfunction, (vii) recent
trans-meridian travel (i.e. potential for jet lag) or regular
shift work.
Assessments

As described previously, participants completed a
detailed clinical assessment conducted with a structured
clinical proforma (Hickie et al. 2014; Scott et al. 2014,
2015). For this study, the following data were used:
1. Demographics—current age and gender.
2. Clinical history—a research psychologist or psychiatrist established that the individual had a UP or BD
that met DSM-IV R diagnostic criteria. Although the
cases were presenting to clinical services for the first
time with syndromal illness episodes, this was not
necessarily the first experience of clinical symptoms
or sub-threshold syndromes. As such, we included a
measure of time since onset of any symptoms, which
is referred to as the duration of illness (and was
estimated as current age minus age at first onset of
any psychiatric symptoms) (Scott et al. 2014). Basic
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details of current medications (class of medications prescribed) and body mass index (BMI) were
recorded.
3. Symptom severity—observer ratings of mood symptoms were undertaken using the 17-item version of
the Hamilton Rating Scale for Depression (HRSD;
Hamilton, 1960) and the 11-item version of the
Young Mania Rating Scale (YMRS) (Young et al.
1978) in all participants.
4. Sleep profile—self-report and observer-rated assessments of sleep were undertaken for other studies by
the research group, but are not reported here (for
details see Robillard et al. 2014).
In this study, objective recordings of sleep profile were
undertaken for between 5 and 14 days (median 10 days)
using an actiwatch (Actiwatch-64/L/2/Spectrum, Philips
Respironics, USA) and sleep–wake detection was conducted automatically with Actiware 5.0 software (Philips
Respironics) using the medium sensitivity threshold.
To characterise the circadian profile of the activity-rest
cycle, individual actigraphy datasets were fitted to an
extended Cosinor model using GraphPad Software. In
this study, we estimated three key parameters, namely:
(i)		 Amplitude: a measure of the range of activity levels
across the 24-h period,
(ii)		 Acrophase: a phase marker that can be used as a
measure of an advance or delay in time of maximum activity, and
(iii) Circadian Rhythmicity Index (R2): an indicator of the
strength or robustness of circadian rhythms, and also
referred to as R2 or the coefficient of determination.
The circadian rhythmicity index is a ‘goodness of fit’
measure and higher values indicate smaller discrepancies between actigraphy data and values predicted
by the Cosinor model and higher scores represent
more robust rhythms (for an explanation of how to
undertake the analysis see Marler et al. 2006).
Statistical analyses

All analyses used an alpha of 0.05 and were conducted
using SPSS (version 21).
Clinical and demographic characteristics for the UP
and BD groups were compared using univariate analyses (t-tests, Mann–Whitney U and Fisher’s exact test).
Pearson’s product moment correlational analyses were
used to examine any associations between each circadian
parameter (amplitude, acrophase and R2) and continuous
variables measuring demographic and illness characteristics i.e. current age, duration of illness, BMI, HRSD and
YMRS in the total sample. Next, we conducted an analysis of variance (ANOVA) for each circadian parameter
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according to mood disorder subtype (UP or BD) with
gender, current age, duration of illness, BMI, HRSD and
YMRS as covariates.

Results
As shown in Table 1, the groups were well matched for
current age and gender and there were no statistically significant differences in duration of illness, BMI or symptom severity scores. The YMRS scores were not normally
distributed, but the higher median score in the BD group
was not significantly greater than in the UP group. Most
cases of both UP and BP were being prescribed only one
medication, and the majority of the sample received an
antidepressant. Some BD cases were co-prescribed a
mood stabilizer or atypical antipsychotic, but prescribing
patterns did not differ significantly between the diagnostic groups.
For the total sample, the mean amplitude was 2.04 (SD
0.76), the mean acrophase was 16.19 h (SD 1.65) and the
mean R2 was 0.42 (SD 0.13); there were no significant differences according to gender. As shown in Table 2, current age was significantly negatively correlated with R2
(r −0.40; p = 0.001), whilst duration of illness was significantly negatively correlated with amplitude (r −0.25;
p = 0.045) and with R2 (r −0.33; p = 0.01). The BMI
was not associated with any circadian parameters. With
regard to current symptom severity, the HRSD was not
Table 1 Sample characteristics
Unipolar disorder
(N = 33)

Bipolar disorder
(N = 30)

Current age

18.66 (3.01)

19.95 (2.13)

Duration of illness

4.45 (3.59)

5.92 (2.87)

Body Mass Index

23.67 (2.89)

24.05 (4.77)

Hamilton Rating Scale for
Depression

13.97 (7.90)

12.44 (7.08)

Mean (SD)
a

Young Mania Rating Scaleb 2 (0, 3)
Median (IQR)

Mean (SD)

3.5 (1, 5)

Number (%)

Number (%)

20 (61)

19 (63)

Antidepressant

25 (76)

19 (77)

Atypical antipsychotic

5 (15)

7 (23)

Mood stabilizerc

2 (6)

5 (17)

Other

2 (6)

0 (0)

Females
Medicationsd

IQR Interquartile range
a
b
c

t-test: t = 1.94, p = 0.06

Mann–Whitney U test: p = 0.07

Fisher’s exact test: p = 0.09

d
Total for all medications exceeds 100 % as some individuals were
prescribed >1 medication
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Table 2 Correlations between clinical characteristics and circadian parameters
Current age
Amplitude

0.06

Acrophase

0.21

Circadian rhythmicity index (R2)

−0.40**

Duration of illness
−0.25*
0.12

−0.33**

Body mass index
0.10
0.03
−0.12

HRSD

YMRS

−0.03

−0.10

−0.20

−0.17

0.07

0.28*

*p < 0.05; **p < 0.01 (see text for exact levels of significance)

significantly associated with circadian parameters, but
the YMRS score was significantly positively correlated
with acrophase (r 0.28; p = 0.03).
The ANOVA demonstrated that, after taking into
account potential confounders (age, gender, duration
of illness, BMI, HRSD, YMRS), differences between the
diagnostic groups were significant for R2 (mean UP v.
BD = 0.43 v 0.40; F = 2.34; df = 6, 56; p = 0.044), but not
for amplitude (mean = 2.14 v. 1.84; F = 1.51; p = 0.09) or
acrophase (mean = 16.07 v 16.30 h; F = 1.17; p = 0.33).
As shown in Figs. 1 and 2, symptom severity and diagnostic group were the main to the significant model for
R2. The regression slopes for the correlations between R2
and HRSD or R2 and YMRS are different in BD compared

to UP cases. There is little variation in R2 across different levels of symptom severity in UP, but higher levels of
either manic or depressive symptoms are associated with
a significantly lower circadian rhythmicity index in BD
cases.

Discussion
The study set out to explore two aspects of circadian
rhythms in youth with mood disorders. First, the associations between the selected circadian parameters and
basic demographic and clinical characteristics (independent of mood disorder subtype), and second, whether
any specific parameters were more likely to be disturbed
in UP compared to BD.

Fig. 1 Correlation between Hamilton rating scale for depression score and circadian rhythmicity (R2) in unipolar and bipolar disorders
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Fig. 2 Correlation between Young mania rating scale score and circadian rhythmicity (R2) in unipolar and bipolar disorders

The correlational analyses undertaken in this study
show a relationship between the selected circadian
rhythm parameters, the first treated episode of mood
disorders in youth and current age. First, longer duration of illness (defined as the time since the first onset
of any symptoms) was associated with a reduced circadian rhythmicity index and lower levels of activity over
24 h. Second, there was a significant inverse correlation between increasing age and robustness of circadian
rhythmicity. Third, acrophase was associated with current mental state, being significantly correlated with the
level of manic but not depressive symptoms.
Taken together, these findings could suggest that weakened rhythmicity and lower 24-h activity are markers of
vulnerability to developing syndromal episodes of UP
or BD. We cannot state categorically that they are trait
markers for UP or BD as, even in this first-treated sample, many individuals had a history of subsyndromal
symptoms. So, the circadian disturbances could be a
consequence of longer duration of symptoms. However,
we can hypothesis that these circadian parameters are
indicators that mood symptoms will meet the diagnostic
threshold for a full syndromal episode (Bullock and Murray 2014; Castro et al. 2015). In contrast, the acrophase

findings suggest that the timing of maximum activity
may be a state marker of manic symptom severity. This
finding is in line with some but not all previous studies.
Several studies in young people failed to show an association between acrophase and depression (Teicher et al.
1993; Robillard et al. 2015), whilst several studies in older
adults have noted an association between mania and
acrophase (although findings are inconsistent with regard
to phase advance or delay) (Salvatore et al. 2008; Ng et al.
2015).
We suggest that the findings regarding current age are
important as they emphasise that there is a developmental
trajectory for the variability in 24-h rhythms that should
be taken into account when planning studies of sleep and
mood disorders (Mansour et al. 2005; Caci et al. 2009; Kim
et al. 2010). This is especially important in studies that
focus on populations of adolescents and young adults, as
age-matching may be needed to avoid misinterpreting any
circadian disruption as an association with illness characteristics as compared to demography (Fares et al. 2015).
Similarly, previous studies have demonstrated an association between gender and/or increased BMI and circadian
disturbance in adolescents and young adults (e.g. Arora
and Taheri 2014; Tranel et al. 2015), and we suggest that
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these factors also need to be routinely reported in future
studies. The lack of significant associations between gender and circadian disturbance may be due to recruiting
a post-pubertal sample (or the sample size); but the lack
of association between BMI and circadian disturbance
was somewhat unexpected. It may be because the sample did not manifest high levels of obesity (the mean BMI
was <25) or it may be a consequence of the relatively small
sample size (Boudebesse et al. 2015).
The examination of mood disorder subtypes suggests
that the circadian rhythmicity index demonstrates a
stronger association with illness episodes in BD as compared to UP. After taking into account possible confounders, we found that rhythmicity in BD was lower than in
UP. Furthermore, whilst there were little apparent differences in rhythmicity across all levels of symptom severity in UP, reduced rhythmicity was associated with both
higher HRSD and higher YMRS scores in BD. A difference between UP and BD might be anticipated for R2 and
YMRS scores, as we would not anticipate high levels of
manic-like symptoms in the UP group and also, previous
publications suggest that there is heightened variability in
circadian markers across mood phases in BD (Novakova
et al. 2015). However, the finding that the BD group, but
not the UP group, also showed lower rhythmicity in association with higher levels of depressive symptoms is an
important finding that warrants replication. The findings
may indicate that weakened circadian rhythms, especially
associated with increasing severity of depressive symptoms, is a more specific marker of BD than of UP in youth.
The current study has a number of limitations. First,
the sample size limits the number of statistical analyses
that could be planned and performed. Also, it meant
we could not justify undertaking any further sub-group
analyses to determine if any specific constellations of
manic or depressive symptoms were associated with
weakened rhythmicity (as reported by Gonzalez et al.
2014). Second, although the age range was limited to the
post-pubertal and early adult period, there were trends
towards significant differences between the UP and BD
groups in mean age (p = 0.06) and the BD group had a
longer mean duration of symptoms. Without specific age
and gender matching, we cannot rule out the possibility
that these differences contributed to some extent to the
findings in this study. Third, although the cases were presenting to the clinical services for the first time, the study
participants were nearly all receiving medication by the
time they undertook the actigraphy recording of their
sleep–wake patterns. Although there were no significant
differences in medications received by the UP and BD
cases, it is possible that some findings might be associated with, or the findings were enhanced by any effects
associated with the medications prescribed. Lastly,
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although symptom levels were in the mild to moderate
range, it does make it difficult to distinguish state and
trait abnormalities in circadian rhythms.

Conclusions
In conclusion, the study selected circadian markers (acrophase, amplitude and circadian rhythmicity) that are easy
to interpret clinically and that capture a holistic picture
of circadian rhythm disruption in mood disorders. The
findings provide evidence for circadian disturbances in
youth with mood disorders that warrant further investigation, especially the possibility that the circadian rhythmicity index is lower in BD compared to UP and is less
robust in the face of increasing levels of manic or depressive symptoms.
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